The management of COL4A1 mutation patients involves a comprehensive approach, including detailed clinical assessments and molecular testing for COL4A1, especially in cases of unexplained brain hemorrhage, porencephaly, or eye abnormalities [16]. Here, COL4A1 is linked to intracranial hemorrhage.